Researchers report that pancreatic cancer cells continually reshape their genetic makeup over time, helping them evade treatment and potentially spread. The findings come from analyses of hundreds of thousands of cells taken from patients’ tumors, alongside laboratory work examining how these changes emerge and persist.
Across the coverage, outlets emphasize that the cancer’s DNA rewiring is linked to increased aggressiveness and treatment resistance. One study also reports that interfering with a key gene can reverse at least some of the dangerous changes observed in experiments, pointing to a possible new therapeutic approach. While the overall takeaway is consistent—pancreatic tumors adapt at the genetic level—different sources frame the work either around large-scale patient cell profiling or around the lab-based demonstration of reversibility.
